|
Conference Program The International Narcotics Research Conference
2008
Charleston, South Carolina, U.S.A.
Final
update/corrections to program schedule
Preliminary
version of program (PDF)
One-page
schedule of conference (PDF)
FOUNDERS LECTURE:
Prof. Jan M. van Ree
Chair, Neuroscience Research Programme
UMC Utrecht, The Netherlands
"Love for endorphins and beyond"
Plenary lectures:
Plenary Lecture I: Peter Kalivas, MUSC
Drug addiction as a
pathology of staged neuroplasticity
Plenary Lecture II: Gary Aston-Jones, MUSC
Orexin neurons, reward-seeking and
addiction
Plenary Lecture III: Sam Deadwyler, Wake Forest U
Endocannabinoids
INRC 2008 Charleston-Symposia topics
Major
Topics
1.
Drug Seeking: Reconsolidation and
Disruption (Alberini/Marshall)
John Marshall (UCI) Reconsolidation of cocaine
memories: Molecular mechanisms and role of extinction
Christine Alberini (Mount Sinai, New York)
Reconsolidation and acute withdrawal of morphine conditioned place
preference
Rita Fuchs (UNC Chapel Hill) Neural substrates
of context-cocaine memory reconsolidation processes that facilitate relapse
to cocaine-seeking behavior
Jean-Antoine Girault (Institut du fer a Moulin)
Signaling pathways and drug-associated memories
2.
Opioid Regulation of Reward System
(Shippenberg/Nyberg)
Vladimir Chefer (NIDA IRP) Delta Opioid Receptor
Regulation of Mesoaccumbal DA Neurotransmission: Glutamatergic and GABAergic
Mechanisms
Alexander Kuzmin (Karolinska Institute): The
Nociceptin/ORL-1 Receptor Brain System as a Novel Target for Treatment of
Alcoholism
Elyssa Margolis
(Gallo Institute): Delta opioid receptor modulation of GABA release
in the ventral tegmental area correlates with ethanol consumption
3.
Genetics and Genomics in Drug Addiction
Steve LaForge Memorial
Symposium (Hurd/Kreek)
Mary
Jeanne Kreek Stress Responsivity and the Addictions: Possible Role of
Gene Variants
Yasmin Hurd Polymorphism of enkephalin and dynorphin opioid systems in
relation to heroin abuse and neurobiology
Ichiro Sora Human genetics of psychostimulant dependence
4. Opioid Receptor
Regulation and Signaling
(Evans/Chavkin)
Ping Law (Univ Minnesota) Receptor location on
and consequences of agonist-selective signaling
Michael Bruchas (Univ Washington) Stress-induced
release of dynorphin produces dysphoria by KOPr activation of p38 MAPK in
mouse brain
Susan George
(U Toronto) Coordinated regulation of mu and delta
opioid receptors within the mu-delta heterooligomer
5.
Translational
Studies in Depression and Opioids (Traynor/Malcolm)
William Carlezon
(McLean/Harvard) Kappa-opioid receptors in the study and treatment of
psychiatric illness
Emily Jutkiewicz
(U MI Ann Arbor) Delta opioids in animal models of depression
Edward Nunes
(Columbia) Depression and Opioid Dependence: Implications for
Diagnosis and Treatment
6.
Molecular Dysregulation in the
dynorphin/KOR system:
relevance for the “dark side of addiction” (Bakalkin/Edenberg)
Georgy Bakalkin (Karolinska Institute) Molecular
regulation of dynorphins in animal and human brain: relevance for alcoholism
Howard Edenberg (Indiana University) Association
of the dynorphin/kappa-opioid system with alcohol dependence
Jose Naranjo (National Center for Biotechnology,
Madrid, Spain): Reduced kappa-opioid tone in DREAM transgenic mice: effect
on cocaine addiction
7. In vivo opioid imaging (Kieffer/Zubieta)
Jon-Kar Zubieta (U MI)
Opioid system function in humans relate to impulsivity and reward
responses
Jeffrey Dalley
(Cambridge U) Neurobiology and
genetics of drug abuse vulnerability
Brigitte Kieffer (Institut
de Génétique et de Biologie Moléculaire et Cellulaire, France)
Delta opioid receptor imaging in vivo
NIDA Workshop (David Shurtleff/Christine Colvis)
Christine Colvis (NIDA/NIH) Opportunities for
Screening the NIH Chemical Library
Peter Hodder (Scripps Inst, CA) High Throughput
Screening and Probe Development
Jeff Conn (Vanderbilt U) Discovery of Novel
Allosteric Modulators of the M1 Muscarinic Receptor
Lakshmi Devi (Mt Sinai U Sch Med)
Screening for Allosteric Modulators of mu-delta
Opioid Receptor Heterodimers
cws ppt
|
